HK1117571A1 - Genetic variants of vkorci predicting warfarin sensitivity - Google Patents
Genetic variants of vkorci predicting warfarin sensitivityInfo
- Publication number
- HK1117571A1 HK1117571A1 HK08108714.0A HK08108714A HK1117571A1 HK 1117571 A1 HK1117571 A1 HK 1117571A1 HK 08108714 A HK08108714 A HK 08108714A HK 1117571 A1 HK1117571 A1 HK 1117571A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- vkorci
- genetic variants
- polymorphism
- warfarin sensitivity
- warfarin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63883704P | 2004-12-21 | 2004-12-21 | |
| US67969405P | 2005-05-10 | 2005-05-10 | |
| PCT/US2005/046869 WO2006069339A2 (en) | 2004-12-21 | 2005-12-21 | Genetic variants of vkorci predicting warfarin sensitivity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1117571A1 true HK1117571A1 (en) | 2009-01-16 |
Family
ID=36602356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK08108714.0A HK1117571A1 (en) | 2004-12-21 | 2008-08-07 | Genetic variants of vkorci predicting warfarin sensitivity |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20060166239A1 (pt) |
| EP (2) | EP2246445A1 (pt) |
| JP (1) | JP4516990B2 (pt) |
| KR (1) | KR101178463B1 (pt) |
| CN (1) | CN101142322B (pt) |
| AT (1) | ATE470725T1 (pt) |
| AU (1) | AU2005319028B2 (pt) |
| BR (1) | BRPI0519570A2 (pt) |
| CA (1) | CA2591840C (pt) |
| DE (1) | DE602005021821D1 (pt) |
| DK (1) | DK1831402T3 (pt) |
| ES (1) | ES2347167T3 (pt) |
| HK (1) | HK1117571A1 (pt) |
| MX (1) | MX2007007568A (pt) |
| NZ (1) | NZ556461A (pt) |
| PL (1) | PL1831402T3 (pt) |
| PT (1) | PT1831402E (pt) |
| TW (1) | TWI334886B (pt) |
| WO (1) | WO2006069339A2 (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8688385B2 (en) | 2003-02-20 | 2014-04-01 | Mayo Foundation For Medical Education And Research | Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype |
| WO2004074456A2 (en) | 2003-02-20 | 2004-09-02 | Mayo Foundation For Medical Education And Research | Methods for selecting medications |
| EP2380985B1 (en) | 2003-09-23 | 2014-01-01 | University of North Carolina at Chapel Hill | Cells expressing vitamin K epoxide reductase and use thereof |
| US7445896B2 (en) * | 2004-10-18 | 2008-11-04 | University Of Washington | Methods and compositions for detecting VKORC1 single nucleotide polymorphisms |
| JP2008532544A (ja) * | 2005-03-15 | 2008-08-21 | ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 活性ビタミンｋ依存性タンパク質を生産するための方法及び組成物 |
| ES2529211T3 (es) * | 2005-11-29 | 2015-02-18 | Children's Hospital Medical Center | Optimización e individualización de la selección y dosificación de medicamentos |
| WO2007133506A2 (en) * | 2006-05-09 | 2007-11-22 | University Of Louisville Research Foundation , Inc. | Personalized medicine management software |
| US8039212B2 (en) * | 2007-11-05 | 2011-10-18 | Celera Corporation | Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof |
| US8688416B2 (en) * | 2008-10-20 | 2014-04-01 | Michael Fearon | Methods and systems for improved pharmaceutical intervention in coagulation control |
| KR101157135B1 (ko) * | 2008-12-29 | 2012-06-18 | 인제대학교 산학협력단 | 항응고제의 약물반응과 관련된 유전자의 변이 유전형 결정방법 |
| EP2233580A1 (en) * | 2009-03-05 | 2010-09-29 | The Ohio State University | Rapid genotyping of SNPs |
| CN102268476B (zh) * | 2010-06-01 | 2014-02-19 | 爱科来株式会社 | Vkorc1基因的第-1639位碱基的多态性检测方法、以及用于该方法的核酸探针和试剂盒 |
| US9631002B2 (en) | 2010-12-21 | 2017-04-25 | The University Of North Carolina At Chapel Hill | Methods and compositions for producing active vitamin K-dependent proteins |
| TWI564392B (zh) * | 2012-08-21 | 2017-01-01 | 財團法人工業技術研究院 | 偵測生物材料的系統及方法 |
| CN103173443B (zh) * | 2013-03-22 | 2016-08-24 | 卫生部北京医院 | 包括1300a>t突变的cyp2c9基因片段、所编码的蛋白质片段及其应用 |
| EP3551753B1 (en) | 2016-12-09 | 2022-06-29 | The Broad Institute, Inc. | Crispr effector system based diagnostics |
| US11174515B2 (en) | 2017-03-15 | 2021-11-16 | The Broad Institute, Inc. | CRISPR effector system based diagnostics |
| US10249389B2 (en) * | 2017-05-12 | 2019-04-02 | The Regents Of The University Of Michigan | Individual and cohort pharmacological phenotype prediction platform |
| DK3746568T5 (da) | 2018-01-29 | 2024-08-26 | Broad Inst Inc | Crispr-effektorsystembaseret diagnostik |
| US20220220546A1 (en) | 2019-03-14 | 2022-07-14 | The Broad Institute, Inc. | Sherlock assays for tick-borne diseases |
| CN110592206A (zh) * | 2019-09-11 | 2019-12-20 | 上海交通大学 | 一种利用rs9934438检测华法药效的试剂盒 |
| KR102506347B1 (ko) | 2021-05-11 | 2023-03-03 | 충북대학교 산학협력단 | 와파린 치료에 따른 출혈 부작용 위험 예측용 다형성 마커 및 이를 이용한 와파린 치료에 따른 출혈 부작용 위험 예측 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6492115B1 (en) * | 2000-06-02 | 2002-12-10 | Dna Sciences Laboratories, Inc. | Genetic typing of the human cytochrome P450 2A6 gene and related materials and methods |
| EP2380985B1 (en) * | 2003-09-23 | 2014-01-01 | University of North Carolina at Chapel Hill | Cells expressing vitamin K epoxide reductase and use thereof |
| WO2006044686A2 (en) * | 2004-10-18 | 2006-04-27 | University Of Washington | Methods and compositions for predicting drug responses |
| US7445896B2 (en) * | 2004-10-18 | 2008-11-04 | University Of Washington | Methods and compositions for detecting VKORC1 single nucleotide polymorphisms |
| US20080005732A1 (en) * | 2006-05-11 | 2008-01-03 | Coon Robert F | Method and System for Integrating Software Update Services with Software Applications |
-
2005
- 2005-12-21 WO PCT/US2005/046869 patent/WO2006069339A2/en active Application Filing
- 2005-12-21 MX MX2007007568A patent/MX2007007568A/es active IP Right Grant
- 2005-12-21 CN CN2005800485213A patent/CN101142322B/zh active Active
- 2005-12-21 DK DK05855433.8T patent/DK1831402T3/da active
- 2005-12-21 CA CA2591840A patent/CA2591840C/en active Active
- 2005-12-21 NZ NZ556461A patent/NZ556461A/en unknown
- 2005-12-21 PT PT05855433T patent/PT1831402E/pt unknown
- 2005-12-21 JP JP2007548549A patent/JP4516990B2/ja active Active
- 2005-12-21 AU AU2005319028A patent/AU2005319028B2/en active Active
- 2005-12-21 DE DE602005021821T patent/DE602005021821D1/de active Active
- 2005-12-21 EP EP10165009A patent/EP2246445A1/en not_active Withdrawn
- 2005-12-21 AT AT05855433T patent/ATE470725T1/de active
- 2005-12-21 US US11/316,406 patent/US20060166239A1/en not_active Abandoned
- 2005-12-21 EP EP05855433A patent/EP1831402B1/en active Active
- 2005-12-21 PL PL05855433T patent/PL1831402T3/pl unknown
- 2005-12-21 TW TW094145510A patent/TWI334886B/zh active
- 2005-12-21 KR KR1020077016947A patent/KR101178463B1/ko active IP Right Grant
- 2005-12-21 BR BRPI0519570-5A patent/BRPI0519570A2/pt active Search and Examination
- 2005-12-21 ES ES05855433T patent/ES2347167T3/es active Active
-
2008
- 2008-08-07 HK HK08108714.0A patent/HK1117571A1/xx unknown
-
2010
- 2010-03-12 US US12/722,672 patent/US20110236885A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2591840A1 (en) | 2006-06-29 |
| EP2246445A1 (en) | 2010-11-03 |
| DE602005021821D1 (de) | 2010-07-22 |
| WO2006069339A2 (en) | 2006-06-29 |
| KR101178463B1 (ko) | 2012-09-07 |
| US20110236885A1 (en) | 2011-09-29 |
| EP1831402B1 (en) | 2010-06-09 |
| JP2008523844A (ja) | 2008-07-10 |
| TWI334886B (en) | 2010-12-21 |
| TW200637918A (en) | 2006-11-01 |
| NZ556461A (en) | 2009-12-24 |
| ATE470725T1 (de) | 2010-06-15 |
| CA2591840C (en) | 2012-07-10 |
| JP4516990B2 (ja) | 2010-08-04 |
| CN101142322B (zh) | 2011-09-21 |
| EP1831402A2 (en) | 2007-09-12 |
| CN101142322A (zh) | 2008-03-12 |
| WO2006069339A3 (en) | 2006-10-12 |
| WO2006069339A8 (en) | 2010-06-03 |
| PT1831402E (pt) | 2010-09-10 |
| MX2007007568A (es) | 2008-03-11 |
| ES2347167T3 (es) | 2010-10-26 |
| US20060166239A1 (en) | 2006-07-27 |
| PL1831402T3 (pl) | 2010-12-31 |
| BRPI0519570A2 (pt) | 2009-01-27 |
| KR20080005179A (ko) | 2008-01-10 |
| AU2005319028B2 (en) | 2010-09-16 |
| DK1831402T3 (da) | 2010-09-20 |
| AU2005319028A1 (en) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1117571A1 (en) | Genetic variants of vkorci predicting warfarin sensitivity | |
| IL225203A (en) | An isolated complementary factor polypeptide, methods for its preparation, its uses and a factor that lowers its expression or activity | |
| PL1747269T3 (pl) | Rekombinowany enzym o zmienionej wrażliwości na sprzężenie zwrotne | |
| EP1788081A4 (en) | REAGENT CONTAINING PROTEASE REACTION PROMOTER AND / OR DYE STABILIZER | |
| WO2008048119A3 (en) | Methods of analysis of polymorphisms and uses thereof | |
| GB2477868A (en) | Methods and systems for incorporating multiple environmental and genetic risk factors | |
| DK1842920T3 (da) | Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein | |
| ATE408032T1 (de) | Esr1 und gebärmutterhalskrebs | |
| WO2007039290A3 (en) | Methods and nucleic acids for the analysis of gene expression associated with the prognosis of cell proliferative disorders | |
| WO2006028999A3 (en) | Assessment of ctla-4 polymorphisms in ctla-4 blockade therapy | |
| SG191078A1 (en) | Improved method and kit for determining severity and progression of periodontal disease | |
| ZA200710910B (en) | Methods for the assessment of risk of developing lung cancer using analysis of genetic polymorphisms | |
| WO2005112568A3 (en) | Haplotype markers and methods of using the same to determine response to treatment | |
| PT1529116E (pt) | Métodos para o tratamento da demência com base no genótipo da apo e | |
| ATE540966T1 (de) | Von phenoxazinon abgeleitete neue enzymsubstrate und deren verwendung als entwickler bei der detektion von mikroorganismen mit peptidaseaktivität | |
| AP2007004058A0 (en) | Novel spirotropane compounds and methods for the modulation of chemokine receptor activity | |
| WO2008048902A8 (en) | Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease | |
| EP1824853A4 (en) | NEW SPIROTROPAN COMPOUNDS AND METHOD FOR MODULATING THE ACTIVITY OF THE CHEMOKIN RECEPTOR | |
| ATE489483T1 (de) | Assoziation von pde4d-allelvarianten mit schlaganfall | |
| SG133515A1 (en) | Scintillation proximity assay | |
| EP1829979A4 (en) | GENE IDENTIFICATION METHOD WITH VARIABLE EXPRESSION | |
| WO2006133866A3 (en) | Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients | |
| ATE498021T1 (de) | Verwendung genetischer polymorphismen zur vorhersage arzneistoffinduzierter hepatotoxizität | |
| WO2007044433A3 (en) | Genetic polymorphisms predictive of nutritional requirements for choline in subjects | |
| MX2009002931A (es) | Fetuin-a como un biomarcador para la esclerosis multiple. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AM | Amended specification (according sect 146 of patent law) |
Free format text: CORRECTION OF THE ENGLISH NAME OF THE INVENTOR FROM YAUN-TSONG CHENG TO CHEN, YUAN-TSONG. |